These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 6160331)
1. The stereoselective disposition of disopyramide in the dog. Giacomini KM; Giacomini JC; Swezey SE; Harrison DC; Nelson WL; Burke TR; Blaschke TF J Cardiovasc Pharmacol; 1980; 2(6):825-32. PubMed ID: 6160331 [TBL] [Abstract][Full Text] [Related]
2. Stereoselective pharmacokinetics of disopyramide enantiomers in man. Lima JJ; Boudoulas H; Shields BJ Drug Metab Dispos; 1985; 13(5):572-7. PubMed ID: 2865105 [TBL] [Abstract][Full Text] [Related]
3. Disposition kinetics of disopyramide in patients with renal insufficiency. Shen DD; Cunningham JL; Shudo I; Azarnoff DL Biopharm Drug Dispos; 1980; 1(3):133-40. PubMed ID: 7448340 [TBL] [Abstract][Full Text] [Related]
4. Disopyramide kinetics in renal impairment: determinants of interindividual variability. Burk M; Peters U Clin Pharmacol Ther; 1983 Sep; 34(3):331-40. PubMed ID: 6883909 [TBL] [Abstract][Full Text] [Related]
5. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog. Cook CS; Karim A; Sollman P Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and steady-state myocardial uptake of disopyramide in the dog. Karim A; Kook C; Novotney RL; Zagarella J; Campion J Drug Metab Dispos; 1978; 6(3):338-45. PubMed ID: 26556 [TBL] [Abstract][Full Text] [Related]
7. Disopyramide pharmacokinetics during recovery from myocardial infarction. Bryson SM; Cairns CJ; Whiting B Br J Clin Pharmacol; 1982 Mar; 13(3):417-21. PubMed ID: 7059444 [TBL] [Abstract][Full Text] [Related]
8. The effects of urine pH and plasma protein binding on the renal clearance of disopyramide. Cunningham JL; Shen DD; Shudo I; Azarnoff DL Clin Pharmacokinet; 1977; 2(5):373-83. PubMed ID: 21054 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of oral disopyramide phosphate in patients with renal impairment. Johnston A; Henry JA; Warrington SJ; Hamer NA Br J Clin Pharmacol; 1980 Sep; 10(3):245-8. PubMed ID: 7437241 [TBL] [Abstract][Full Text] [Related]
10. Stereoselective metabolism and pharmacokinetics of disopyramide enantiomers in humans. Le Corre P; Gibassier D; Sado P; Le Verge R Drug Metab Dispos; 1988; 16(6):858-64. PubMed ID: 2907466 [TBL] [Abstract][Full Text] [Related]
11. The effect of saturable binding to plasma proteins on the pharmacokinetic properties of disopyramide. Giacomini KM; Swezey SE; Turner-Tamiyasu K; Blaschke TF J Pharmacokinet Biopharm; 1982 Feb; 10(1):1-14. PubMed ID: 7069575 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of disopyramide in patients with chronic renal failure. Francois B; Mallein R; Rondelet J; Lussignol M Eur J Drug Metab Pharmacokinet; 1983; 8(1):85-92. PubMed ID: 6861798 [TBL] [Abstract][Full Text] [Related]
14. Effect of concentration-dependent binding to plasma proteins on the pharmacokinetics and pharmacodynamics of disopyramide. Giacomini KM; Blaschke TF Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():42-8. PubMed ID: 6705426 [TBL] [Abstract][Full Text] [Related]
15. Disopyramide pharmacokinetics and bioavailability following the simultaneous administration of disopyramide and 14C-disopyramide. Lima JJ; Haughey DB; Leier CV J Pharmacokinet Biopharm; 1984 Jun; 12(3):289-313. PubMed ID: 6502472 [TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of disopyramide and mono-N-dealkyl-disopyramide in humans. Aitio ML; Allonen H; Kanto J; Mäntylä R Int J Clin Pharmacol Ther Toxicol; 1982 May; 20(5):219-26. PubMed ID: 7095921 [TBL] [Abstract][Full Text] [Related]
17. The influence of protein binding on disopyramide clearance. Bryson SM; Lawrence JR; Steele WH; Campbell BC; Elliott HL; Sumner DJ Eur J Clin Pharmacol; 1982; 23(5):453-6. PubMed ID: 7151851 [TBL] [Abstract][Full Text] [Related]
18. Disopyramide serum and pharmacologic effect kinetics applied to the assessment of bioavailability. Bryson SM; Whiting B; Lawrence JR Br J Clin Pharmacol; 1978 Nov; 6(5):409-19. PubMed ID: 728284 [TBL] [Abstract][Full Text] [Related]
19. Influence of concentration-dependent protein binding on serum concentrations and urinary excretion of disopyramide and its metabolite following oral administration. Haughey DB; Lima JJ Biopharm Drug Dispos; 1983; 4(2):103-12. PubMed ID: 6882879 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of disopyramide in patients with imminent to moderate cardiac failure. Landmark K; Bredesen JE; Thaulow E; Simonsen S; Amlie JP Eur J Clin Pharmacol; 1981 Feb; 19(3):187-92. PubMed ID: 7215416 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]